Tenet Healthcare (NYSE:THC) Price Target Cut to $242.00 by Analysts at Guggenheim

Tenet Healthcare (NYSE:THC) had its target price decreased by Guggenheim from $252.00 to $242.00 in a research report released on Monday, Marketbeat Ratings reports. Guggenheim currently has a buy rating on the stock.

A number of other equities analysts have also recently weighed in on the company. Royal Bank Of Canada lowered their price target on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a report on Friday, May 1st. Barclays upped their target price on shares of Tenet Healthcare from $238.00 to $240.00 and gave the company an “overweight” rating in a research report on Wednesday, July 8th. TD Cowen dropped their price target on shares of Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating for the company in a research report on Monday, June 22nd. Wells Fargo & Company upped their price objective on shares of Tenet Healthcare from $213.00 to $231.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Finally, Morgan Stanley set a $254.00 price objective on shares of Tenet Healthcare in a research report on Friday, May 1st. Eighteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $244.84.

Tenet Healthcare Stock Down 0.2%

Shares of NYSE THC opened at $194.43 on Monday. The company has a market capitalization of $16.75 billion, a P/E ratio of 10.11, a P/E/G ratio of 1.61 and a beta of 1.27. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. The company has a 50 day simple moving average of $184.41 and a 200-day simple moving average of $197.41. Tenet Healthcare has a 1 year low of $146.60 and a 1 year high of $247.21.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, topping the consensus estimate of $4.21 by $0.61. The company had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.During the same period in the prior year, the business posted $4.36 earnings per share. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, equities research analysts predict that Tenet Healthcare will post 17.5 earnings per share for the current year.

Insider Transactions at Tenet Healthcare

In related news, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the sale, the director directly owned 16,804 shares of the company’s stock, valued at $2,932,634.08. This represents a 25.12% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the transaction, the director directly owned 24,805 shares of the company’s stock, valued at $4,399,166.75. This represents a 10.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.97% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Triumph Capital Management purchased a new stake in Tenet Healthcare during the 3rd quarter worth about $25,000. Activest Wealth Management acquired a new position in shares of Tenet Healthcare during the fourth quarter worth about $26,000. Elyxium Wealth LLC purchased a new stake in shares of Tenet Healthcare during the fourth quarter worth approximately $29,000. Meeder Asset Management Inc. raised its holdings in Tenet Healthcare by 146.2% in the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after acquiring an additional 114 shares in the last quarter. Finally, Canada Pension Plan Investment Board purchased a new position in Tenet Healthcare in the second quarter worth approximately $35,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.